Target pilots new model for clinics

Print Friendly, PDF & Email

MINNEAPOLIS — Target Corp. is testing a new in-store clinic model in collaboration with Kaiser Permanente.

The companies have launched four Target Clinics in Southern California offering services typically unavailable in retail clinics. Expanded services include pediatric, adolescent and well-woman care, family planning, and management of chronic conditions such as diabetes and high blood pressure.

The clinics — in Vista, San Diego, Fontana and West Fullerton — will provide care to Kaiser members and nonmembers.

Kaiser will staff the clinics with nurse practitioners and vocational nurses, and will have physicians available for telemedicine consultations. The clinics will combine Kaiser’s technologically advanced care delivery system and Target’s focus on customer service.

“We believe our stores are uniquely equipped to offer guests a comprehensive approach to supporting their wellness needs, including Target Clinic, Target pharmacy, healthy foods and wellness products,” said Dr. Kevin Ronne­berg, the discounter’s medical director. “We look forward to working with Kaiser Permanente to make their exceptional care and services available to the entire community, while ushering in the next generation of health care service models.”

Kaiser is collaborating with Target because the clinics “have a legacy of combining quality and convenience in a way that we think will resonate with both our members and the overall Target guest population,” said Dr. Paul Minardi, the health care company’s medical director for business management for Southern California and Target Clinics. “This is the evolution of expanding Kaiser Permanente’s high-quality and holistic care delivery into a setting that will provide patients with wellness support.”

Target has some 80 clinics in seven states. The new clinics are also contracting with Medicare and MediCal, as well as with Blue Shield of California and other leading health insurance plans in the area for certain services.


Comments are closed.